<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02205112</url>
  </required_header>
  <id_info>
    <org_study_id>TG-873870-C-6</org_study_id>
    <nct_id>NCT02205112</nct_id>
  </id_info>
  <brief_title>A Phase III Study to Evaluate the Efficacy and Safety of Intravenous Infusion of Nemonoxacin in Treating CAP</brief_title>
  <official_title>A Multi-center, Randomized, Double-Blind, Parallel Comparative, Phase III Study to Evaluate the Efficacy and Safety of Intravenous Infusion of Nemonoxacin Versus Levofloxain in Treating Adult Patients With CAP</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TaiGen Biotechnology Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>TaiGen Biotechnology Co., Ltd.</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy, safety and pharmacokinetics of&#xD;
      intravenous nemonoxacin compared with intravenous moxifloxacin in adult patients with&#xD;
      community-acquired pneumonia (CAP).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Community-acquired Pneumonia (CAP) remains a leading cause of death in both developing and&#xD;
      developed countries. In the choice of antibacterial agents used to treat CAP,&#xD;
      fluoroquinolones have received considerable attention because of their wide spectrum of&#xD;
      bactericidal activity. TG-873870 (Nemonoxacin), a non-fluorinated quinolone (NFQ), is a&#xD;
      selective bacterial topoisomerase inhibitor.&#xD;
&#xD;
      This study will evaluate the clinical efficacy, microbiological efficacy and safety of&#xD;
      Intravenous nemonoxacin compared with Intravenous levofloxacin in adult patients with&#xD;
      community-acquired pneumonia.&#xD;
&#xD;
      Besides, the populationpharmacokinetics (PPK) of nemonoxacin in adult patients with CAP after&#xD;
      continuous IV Infusion and the pharmacokinetic (PK)/pharmacodynamic (PD)are to be determined.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Actual">May 15, 2017</completion_date>
  <primary_completion_date type="Actual">May 4, 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Per subject clinical cure rate</measure>
    <time_frame>end of treatment and 7 to 14 days after the end of treatment</time_frame>
    <description>The clinical cure rate will be evaluated according to signs and symptoms and changes in the chest X-ray</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Per subject microbiological cure rate</measure>
    <time_frame>end of treatment and 7 to 14 days after the end of treatment</time_frame>
    <description>The microbiological cure rate will be evaluated according to the microbiological identification results of the central laboratory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Per subject overall cure rate</measure>
    <time_frame>end of treatment and 7 to 14 days after the end of treatment</time_frame>
    <description>Evaluate the overall efficacy after a comprehensive consideration of the clinical results and the bacteriological results.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety evaluation</measure>
    <time_frame>duration of trial</time_frame>
    <description>Incidence and severity of AE and changes in safety parameters from baseline</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">598</enrollment>
  <condition>Community-acquired Pneumonia</condition>
  <arm_group>
    <arm_group_label>Nemonoxacin 500 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nemonoxacin 500mg/250mL, intravenous administration, once daily for 7~14 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Levofloxacin 500mg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Levofloxacin: 500mg/100mL, intravenous administration, once daily for 7~14 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nemonoxacin</intervention_name>
    <arm_group_label>Nemonoxacin 500 mg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levofloxacin</intervention_name>
    <arm_group_label>Levofloxacin 500mg</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Ages between 18 and 80;&#xD;
&#xD;
          2. Weighs between 40 ~ 100 kg, and BMI â‰¥ 18 kg/m2;&#xD;
&#xD;
          3. Must have a clinical diagnosis of CAP&#xD;
&#xD;
          4. Chest X-ray and /or CT scan show new or persist/progressive infiltrates&#xD;
&#xD;
          5. Patients with PORT/PSI score II, III or IV.&#xD;
&#xD;
          6. If female, non-lactating and at no risk or pregnancy (post-menopausal or must use&#xD;
             adequate birth control)&#xD;
&#xD;
          7. Male must use a reliable form of contraception.&#xD;
&#xD;
          8. Able to receive an intravenous infusion of the drug&#xD;
&#xD;
          9. Able to provide an adequate sputum and blood samples&#xD;
&#xD;
         10. Able to provide written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with PORT/PSI score I or VI.&#xD;
&#xD;
          2. Severe CAP is present if a patient needs invasive mechanical ventilation or requires&#xD;
             vasopressors.&#xD;
&#xD;
          3. Healthcare-associated pneumonia, hospital-acquired pneumonia, or hospitalized within&#xD;
             14 days before enrollment&#xD;
&#xD;
          4. Virus pneumonia, aspiration pneumonia, ventilator associated pneumonia, or&#xD;
             intersstitial lung disease&#xD;
&#xD;
          5. Bronchial bostruction (exclusive of COPD), bronchiectasis, cystic fibrosis, known or&#xD;
             suspected pneumocystis pneumonia, known or suspected tuberculosis, primary empyema&#xD;
             thoracis, lung abscess, known or suspected lung cancer, or lung disease associated&#xD;
             with autoimmune disorders.&#xD;
&#xD;
          6. Medical history of QT prolongation, require the treatment of arrhythmia using class IA&#xD;
             or class III drugs, or NYHA functional class &gt;/= III&#xD;
&#xD;
          7. Clinically significant findings on 12-lead ECG, QTc interval&gt;450ms or potassium is &lt;&#xD;
             3.5 mmol/L or lower limit of normal at Screening&#xD;
&#xD;
          8. Immunocompromising illness, such as HIV infection&#xD;
&#xD;
          9. Fatal progressive disease or neurodegenerative diseases that prevent patients from&#xD;
             effectively clearing pulmonary secretions&#xD;
&#xD;
         10. Have medical history of seizure, alcohol or drug abuse, suicide tendency, or psychosis&#xD;
             that can effect the compliance&#xD;
&#xD;
         11. Have diseases that may affect intravenous infusion.&#xD;
&#xD;
         12. Active hepatitis or decompensated cirrhosis with ascites (Child-Pugh score 10-15/class&#xD;
             C);&#xD;
&#xD;
         13. Renal Insufficiency or creatinine &gt;/= 1.1 ULN within 24 hr before first dose&#xD;
&#xD;
         14. ALT or AST &gt;/= 3x ULN, or BUN &gt;/= 30 mg/dL within 24 hr before first dose&#xD;
&#xD;
         15. Neutrophil &lt; 1000 mm3 within 24 hr before first dose&#xD;
&#xD;
         16. Received systemic antibiotics within 72 hr before first dose&#xD;
&#xD;
         17. Received probenecid within 24 hr before first dose or require the treatment with&#xD;
             probenecid during study&#xD;
&#xD;
         18. Received quinolones or fluoroquinolones within 14 days before first dose&#xD;
&#xD;
         19. Received any investigational drugs within 30 days before first dose&#xD;
&#xD;
         20. Require the treatment with other systemic antibiotics during study&#xD;
&#xD;
         21. Patients who are being or will be on a long-term medication (over 2 weeks) of steroids&#xD;
             (20mg/day)&#xD;
&#xD;
         22. Medical history of hypersensitivity to any quinolone, fluoroquinolone-associated&#xD;
             tendinitis and tendon rupture, or myasthenia gravis&#xD;
&#xD;
         23. Current condition or abnormality that, in the opinion of the investigator, would&#xD;
             compromise the safety of the subject or the quality of the data&#xD;
&#xD;
         24. Participated and received the study medication in previous clinical trials&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Baotou Central Hospital</name>
      <address>
        <city>Baotou</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aerospace Center Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Affiliated Beijing Anzhen Hospital of Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Affiliated Beijing Chaoyang Hospital of Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chinese People's Liberation Army General Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute of Clinical Pharmacology, Peking University</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Peking University People's Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Changsha Central Hospital</name>
      <address>
        <city>Changsha</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Third Changsha Hotpital</name>
      <address>
        <city>Changsha</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Third Xiangya Hospital of Central South University</name>
      <address>
        <city>Changsha</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Daping Hospital</name>
      <address>
        <city>Chongqing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Guangxi Zhuang Autonomous Region People's Hospital</name>
      <address>
        <city>Guangxi</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>First Affiliated Hospital of Guangzhou Medical University</name>
      <address>
        <city>Guangzhou</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Guilin Medical School Affiliated Hospital</name>
      <address>
        <city>Guilin</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hainan General Hospital</name>
      <address>
        <city>Haikou</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sir Run Run Shaw Hospital Zhejiang University School of Medicine</name>
      <address>
        <city>Hangzhou</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Second Affiliated Hospital of Zhejiang University</name>
      <address>
        <city>Hangzhou</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Hospital of Anhui Medical University</name>
      <address>
        <city>Hefei</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Affilated Hospital of Inner Mongolia Medical University</name>
      <address>
        <city>Hohhot</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Hospital of Jilin University</name>
      <address>
        <city>Jilin</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Fourth Hospital of Jilin University</name>
      <address>
        <city>Jilin</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jinan Central Hospital</name>
      <address>
        <city>Jinan</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Second Hospital of Shandong University</name>
      <address>
        <city>Jinan</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gansu Provincial People's Hospital</name>
      <address>
        <city>Lanzhou</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jiangxi Provincial People's Hospital</name>
      <address>
        <city>Nanchang</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Second Subsidiary Hospital of Nanchang Medical College</name>
      <address>
        <city>Nanchang</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>General Hospital of Nanjing Military Command</name>
      <address>
        <city>Nanjing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute of Antibiotics, Huashan Hospital, Fundan University</name>
      <address>
        <city>Shanghai</city>
        <zip>200040</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Huadong Hospital Affiliated to Fudan University</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shanghai East Hospital of Tongji University</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shanghai Pulmonary Hospital</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>General Hospital of Shenyang Military</name>
      <address>
        <city>Shenyang</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shengjing Hospital</name>
      <address>
        <city>Shenyang</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shenzhen People's Hospital</name>
      <address>
        <city>Shenzhen</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Second People's Hospital of Shenzhen</name>
      <address>
        <city>Shenzhen</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>General Hospital of Chengdu Military Region</name>
      <address>
        <city>Sichuan</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>West China Center of Medical Sciences of Sichuan University</name>
      <address>
        <city>Sichuan</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>First Hospital of Shanxi Medical University</name>
      <address>
        <city>Taiyuan</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wuxi People's Hospital</name>
      <address>
        <city>Wuxi</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tangdu Hospital</name>
      <address>
        <city>Xi'an</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Affilated Hospital of Xiamen University</name>
      <address>
        <city>Xiamen</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northern Jiangsu People's Hospital</name>
      <address>
        <city>Yangzhou</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital,College of Medicine,Zhejiang University</name>
      <address>
        <city>Zhejiang</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Changhua Christian Hospital</name>
      <address>
        <city>Chang Hua</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chiayi Chang Gung Memorial Hospital</name>
      <address>
        <city>Chiayi City</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NTUH Hsin-Chu Branch</name>
      <address>
        <city>Hsinchu</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hualien Tzu Chi Hospital</name>
      <address>
        <city>Hualien City</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaohsiung Chang Gung Memorial Hospital</name>
      <address>
        <city>Kaohsiung</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaohsiung Medical University Chung-Ho Memorial Hospital</name>
      <address>
        <city>Kaohsiung</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaohsiung Veterans General Hospital</name>
      <address>
        <city>Kaohsiung</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Keelung Chang Gung Memorial Hospital</name>
      <address>
        <city>Keelung</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Far Eastern Memorial Hospital</name>
      <address>
        <city>New Taipei City</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MacKay Memorial Hospital</name>
      <address>
        <city>New Taipei City</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>China Medical University Hospital</name>
      <address>
        <city>Taichung</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chung Shan Medical University Hospital</name>
      <address>
        <city>Taichung</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Taichung Veterans General Hospital</name>
      <address>
        <city>Taichung</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chi Mei Hospital, Liouying</name>
      <address>
        <city>Tainan</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Taipei Medical University - Shuang Ho Hospital</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Taipei Medical University Hospital</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Taipei Municipal Wanfang Hospital</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tri-Service General Hospital</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NTUH Yun-Lin Branch</name>
      <address>
        <city>Yuli</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>July 27, 2014</study_first_submitted>
  <study_first_submitted_qc>July 29, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 31, 2014</study_first_posted>
  <last_update_submitted>October 22, 2021</last_update_submitted>
  <last_update_submitted_qc>October 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>intravenous nemonoxacin</keyword>
  <keyword>community-acquired pneumonia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Levofloxacin</mesh_term>
    <mesh_term>Ofloxacin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

